University of California, San Francisco, Department of Urology, San Francisco, CA 94130, USA.
Pediatrics. 2013 Sep;132(3):437-44. doi: 10.1542/peds.2012-3135. Epub 2013 Aug 5.
To characterize urine test use in ambulatory, antibiotic-treated pediatric urinary tract infection (UTI).
We studied children <18 years who had an outpatient UTI and a temporally associated antibiotic prescription from 2002 through 2007 by using a large claims database, Innovus i3. We evaluated urine-testing trends and performed multivariable logistic regression to assess for factors associated with urine culture use.
Of 40 603 treated UTI episodes in 28 678 children, urinalysis was performed in 76%, and urine culture in 57%; 32% of children <2 years had no urinalysis or culture performed for an antibiotic-treated UTI episode. Urine culture use decreased during the study period from 60% to 54% (P < .001). We observed variation in urine culture use with age (<2 years: odds ratio [OR] 1.0, 95% confidence interval [CI] 0.9-1.1; 2-5 years: OR 1.3, 95% CI 1.2-1.4; 6-12 years: OR 1.3, 95% CI 1.2-1.4, compared with 13-17 years); gender (boys: OR 0.8, 95% CI 0.8-0.9); and specialty (pediatrics: OR 2.6, 95% CI 2.5-2.8; emergency medicine, OR 1.2, 95% CI 1.1-1.3; urology: OR 0.5, 95% CI 0.4-0.6, compared with family/internal medicine). Recent antibiotic exposure (OR 1.1, 95% CI 1.1-1.2) and empirical broad-spectrum prescription (OR 1.2, 95% CI 1.1-1.2) were associated with urine culture use, whereas previous UTI and urologic anomalies were not.
Providers often do not obtain urine tests when prescribing antibiotics for outpatient pediatric UTI. Variation in urine culture use was observed based on age, gender, and physician specialty. Additional research is necessary to determine the implications of empirical antibiotic prescription for pediatric UTI without confirmatory urine testing.
描述门诊抗生素治疗小儿尿路感染(UTI)时尿液检测的应用情况。
我们使用大型理赔数据库 Innovus i3 研究了 2002 年至 2007 年间 28678 名患有门诊 UTI 且同时开具抗生素处方的 18 岁以下儿童。我们评估了尿液检测趋势,并进行多变量逻辑回归分析以评估与尿液培养应用相关的因素。
在 40603 例接受治疗的 UTI 发作中,28678 例患儿中有 76%进行了尿液分析,57%进行了尿液培养;32%的<2 岁儿童在接受抗生素治疗的 UTI 发作时未进行尿液分析或培养。在此研究期间,尿液培养的应用从 60%下降至 54%(P<0.001)。我们观察到尿液培养的应用存在年龄差异(<2 岁:比值比 [OR] 1.0,95%置信区间 [CI] 0.9-1.1;2-5 岁:OR 1.3,95% CI 1.2-1.4;6-12 岁:OR 1.3,95% CI 1.2-1.4,与 13-17 岁比较);性别(男孩:OR 0.8,95% CI 0.8-0.9);以及科室(儿科:OR 2.6,95% CI 2.5-2.8;急诊医学:OR 1.2,95% CI 1.1-1.3;泌尿科:OR 0.5,95% CI 0.4-0.6,与家庭/内科比较)。近期抗生素使用(OR 1.1,95% CI 1.1-1.2)和经验性广谱处方(OR 1.2,95% CI 1.1-1.2)与尿液培养的应用相关,而既往 UTI 和泌尿系统异常无此相关性。
医生在为门诊小儿 UTI 开抗生素时,往往不进行尿液检测。尿液培养的应用存在年龄、性别和医生科室的差异。需要进一步研究以确定在没有确认性尿液检测的情况下,经验性抗生素处方对小儿 UTI 的影响。